Prescription drug · ANDA
Tobramycin NDC 59651-129
Tobramycin 300 mg/5mL · Solution · Respiratory (Inhalation) · Aurobindo Pharma Limited
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 59651-129-56 | 5965101295659651012956 | 14 POUCH in 1 CARTON (59651-129-56) / 4 AMPULE in 1 POUCH (59651-129-04) / 5 mL in 1 AMPULEMarketed from Jan 22, 2021 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Tobramycin
- Generic name (nonproprietary)
- tobramycin
- Active ingredients
- Tobramycin — 300 mg/5mL
- Dosage form
- Solution
- Route
- Respiratory (Inhalation)
- Labeler
- Aurobindo Pharma LimitedNDC labeler code 59651
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 210871
- Marketing start
- Listing expires
- Other FDA classes
- Aminoglycosides (Chemical structure)
- Identifiers
- Product ID 59651-129_faec0c96-e264-6fee-e053-6394a90a23caSPL ID faec0c96-e264-6fee-e053-6394a90a23caSPL set ID 0aa5859e-cd80-49c0-881b-47f39d1f1d01RxCUI 348719UNII VZ8RRZ51VK
- Pharmacologic class
- Aminoglycoside Antibacterial
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- NDC on a medical claim
N459651012956followed by a unit qualifier and the quantityPackage 59651-0129-56. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
Tobramycin inhalation solution is indicated for the management of cystic fibrosis in adults and pediatric patients 6 years of age and older with Pseudomonas aeruginosa . Safety and efficacy have not been demonstrated in patients under the age of 6 years, patients with forced expiratory volume in 1 second (FEV 1 ) <25% or >75% predicted, or patients colonized with Burkholderia cepacia [see Clinical Studies (14) ]. Tobramycin inhalation solution is an aminoglycoside antibacterial indicated for the management of cystic fibrosis in adults and pediatric patients 6 years of age and older with Pseudomonas aeruginosa. ( 1 ) Safety and efficacy have not been demonstrated in patients under the age of …
Excerpt only. Read the full label for complete information.
About NDC 59651-129
- What is NDC 59651-129?
- 59651-129 is the product NDC for Tobramycin, Tobramycin 300 mg/5mL solution, listed with the FDA by Aurobindo Pharma Limited. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Tobramycin.
- What is the active ingredient?
- Tobramycin.
- Who is the labeler?
- Aurobindo Pharma Limited, NDC labeler code 59651. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Tobramycin?
- 55 other product NDCs are listed under this name. See all Tobramycin NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Tobramycin products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Tobramycin | Tobramycin 3 mg/mL | SolutionOphthalmic | Preferred Pharmaceuticals Inc. | 68788-4149 | 68788-4149-05 |
| Tobramycin | Tobramycin 3 mg/mL | Solution/ dropsOphthalmic | JVET PHARMACEUTICALS LLC | 86211-110 | 86211-0110-01 |
| Tobramycin | Tobramycin 300 mg/5mL | SolutionRespiratory (Inhalation) | Ritedose Pharmaceuticals, LLC | 76204-029 | 76204-0029-56 |
| Tobramycin | Tobramycin 300 mg/4mL | SolutionRespiratory (Inhalation) | NorthStar RxLLC | 72603-630 | 72603-0630-56 |
| Tobramycin | Tobramycin 300 mg/5mL | SolutionRespiratory (Inhalation) | NorthStar RxLLC | 72603-430 | 72603-0430-56 |
| Tobramycin | Tobramycin 300 mg/5mL | SolutionRespiratory (Inhalation) | American Health Packaging | 60687-731 | 60687-0731-83 |
| Tobramycin | Tobramycin sulfate 1.2 g/30mL | Injection, Powder, Lyophilized, For solutionIntravenous | Northstar Rx LLC | 72603-160 | 72603-0160-06 |
| Tobramycin | Tobramycin 3 mg/mL | Solution/ dropsOphthalmic | Belcher Pharmaceuticals, LLC | 62250-110 | 62250-0110-01 |
| Tobramycintobramycin solution | Tobramycin 300 mg/5mL | InhalantRespiratory (Inhalation) | Micro Labs Limited | 42571-408 | 42571-0408-92 |
| Tobramycin | Tobramycin 300 mg/5mL | SolutionRespiratory (Inhalation) | Lifestar Pharma LLC | 70756-604 | 70756-0604-56 |